-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck's Enflonsia has received the US FDA's application for accelerated breakthrough therapy.

Zhitongcaijing·08/06/2026 10:49:14
Listen to the news
Merck's Enflonsia has received the US FDA's application for accelerated breakthrough therapy.